Introduction
Cleistanthin B is a naturally occurring compound isolated from the plant Cleistanthus collinus (Roxb) Benth and Hook (family Euphorbiaceae). It is a small tree found in dry forests of central and southern India. The plant is extremely poisonous and astringent. Extracts of leaves, roots and fruits are used in acute gastro-intestinal disorders. The extracts are also used as suicidal and homicidal poisons. The active principles isolated from the leaves of C.collinus are cleistanthin B, cleistanthin A, collinusin, diphyllin and elagic acid (Chopra et al, 1965) .
Cleistanthins cause neutrophilic granulocytosis in rats, mice, cats and monkeys (Rao and Nair, 1970) . Granulocytopenia induced by i.p injection of cyclophosphamide could be prevented by the glycoside cleistanthin (Rao and Nair, 1971) . The alcoholic extract of the whole plant exhibited anti-proliferative activity against human epidermal carcinoma of the nasopharynx in tissue culture (Bhakuni et al, 1969) . All patients who succumbed to C.collinus poisoning had cardiac signs in the form of tachycardia followed by brachycardia, low pulse rate, hypotension and arrhythmias (Nagaraj, 1987) . The LDJQ value of cleistanthin B in mice is 1.2 mg/kg body weight. I.v. and i.p. administration of cleistanthin B to rats and rabbits resulted in decreased serum levels of alkaline phosphatase, lactate dehydrogenase, glutamate oxaloacetate transaminase and glutamate pyruvate transaminase. The isoenzyme pattern of lactate dehydrogenase showed that the toxin affects heterologous © UK Environmental Mutagen Society/Oxford University Press 1996 isoenzymes while the homologous isoenzymes remain unaltered (Annapoorni et al, 1986) .
Since the crude extract of C.collinus was shown to possess anti-proliferative activity (Bhakuni et al, 1969) , we initiated this study to determine the cytotoxic and genotoxic effects of the chief toxic principle, cleistanthin B, in a panel of normal and tumour cell lines, with the objective of exploring this toxin as an anti-tumour agent. We investigated the genotoxic effects of cleistanthin B in Chinese hamster ovary (CHO) cells and cultured blood lymphocytes. Genotoxicity was evaluated using DNA strand breaks assay (Olive et al, 1988) , chromatid aberration (CA) analysis (Preston et al., 1981; Ishidate et al, 1988) and micronucleus (MN) assay using cytochalasin B (cyt-B) (Fenech and Morley, 1985) . In addition, we observed that cleistanthin B induces apoptosis in cultured cells.
Materials and methods

Chemicals
Cleistanthin B was purified from C.collinus leaves as previously described (Govindachari et ai, 1969) . Cytochalasin B was dissolved in dimethyl sulphoxide (DMSO) at a concentration of 2 mg/ml and stored at -70°C. At the time of experiment the stock solution was diluted with phosphate-buffered saline (PBS) and added to cultures at a final concentration of 6 Hg/ml. Erythrosin B, cytochalasin B, phytohaemagglutinin (PHA) and 3-{4,5 dimethyl thiazol-2-yl)-2,5 tetrazolium bromide (MTT) were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Cell culture
Primary cultures of human bone marrow fibroblasts (from healthy donors) were from the National Centre for Cell Science, Pune, India. They were maintained in 20% Iscove's modified Dulbecco's medium. For culturing human peripheral blood lymphocytes, venous blood from healthy donors aged 23-31 years were collected using heparinized vacutainer tubes. Lymphocytes were isolated using Ficoll-paque and cultured in Roswell Park Memorial Institute (RPMI) 1640 medium containing 10% fetal calf serum, 2 mM Lglutamine, 100 U/ml penicillin, 100 ug/ml streptomycin and 2% PHA.
All cell lines, except the CHO were cultured in Dulbecco's modified medium plus 10% fetal calf serum and 2 mM L-glutamine and gentamycin sulphate (50 ug/ml) at 37°C in an incubator containing 5% CO?. The CHO cells were maintained in Eagle's modified minimum essential medium (Row Laboratories, Irvine, UK) supplemented with 10% adult bovine serum, 2 mM L-glutamine and gentamycin sulphate (50 ug/ml) (Sigma Chemical Co.).
Cytotoxicity assay
Cells were seeded on 96-well plates (Nunc, Kamstrup, Denmark), cultured for 1 day and then treated with different concentrations of cleistanthin B for 72 h at 37°C in 5% CO2 in a humidified atmosphere. Control cells were grown under identical conditions. At the end of incubation, medium was removed and MTT (5 mg/ml) was added and the cells were further incubated for 4 h. After the incubation, the MTT solution covering the cells was removed, DMSO was added to the wells and cell viability was determined by measuring the absorbance in a MR 700 microplate reader with a test wavelengh of 570 run and a reference wavelengh of 630 nm (Mosmann, 1983) . The experiment was repeated three or four times and the variations were <TH.
Chromatid aberration analysis Subconfluent cultures of CHO cells in 25 cm
2 flasks were incubated with cleistanthin B (1-6 ug/ml) at 37°C for 30 min. Solvent (ethanol 0.05%) and negative controls (without treatment) were maintained separately. After treatment the cells were washed twice with PBS and incubated with fresh medium for 3 h for recovery. Colcemid (Sigma Chemical Co.) at a final concentration of 0.2 uM was added and the cells were incubated further Cervix carcinoma (SiHa) 1,6X 1(T* "GI^ was determined using Mil as described in Materials and Methods.
for 3 h Mitotic cells were collected in a centrifuge tube by gentle shake off. The cells were treated with hypotonic solution of 0.075 M KC1 at 37°C for 2-3 rrun. The cells were then fixed with methanol : acetic acid (3:1). Airdned chromosome preparations were stained with 3% Giemsa solution in Sorenson phosphate buffer (pH 6.8) for 5-7 min. The slides were coded and 200 well-spread metaphases were screened for chromatid aberrations (Evans et al, 1984) .
Micronucleus assay
Human phenpheral blood lymphocytes were exposed to different concentrations of cleistanthin B for 24 and 48 h. After 18 h of culture in the presence of cyt-B (5 |ig/ml), cells were fixed as described above. Two to three drops of fixed cell suspension were dispensed onto the surface of cold microslides. For each donor, 1500 binucleate cells per concentration were scored blind for MN frequency in each treatment (Preston et al. 1981; Ishidate et al, 1988) .
Viability test
About 5X10 3 CHO cells were seeded in 6-well tissue culture plates and treated with desired amounts of the toxin and incubated at 37°C for 24 h in a humidified atmosphere containing 5% CO 5 . After incubation, the cells were trypsinized and resuspended in 0.4% erythrosin B in PBS. The percentage of viable cells was determined by counting stained (dead) and unstained (live) cells. The experiment was repeated three times and the experimental variation was 2-5%.
DNA precipitation assay
Exponentially growing CHO cells were radiolabelled for 20 h with 0 1 |iCi/ ml [ 3 H]-thymidine, (17 Ci/mmole; Bhabha Atomic Research Centre, Bombay, India). DNA precipitation assay (Olive et al, 1988) was carried out using labelled cells that were treated with different doses of cleistanthin B for 24 h. Briefly, cells were harvested with trypsin and about 3.5X 10 5 cells were lysed for 1 min in 0.5 ml solution containing 2% sodium dodecyl sulphate (SDS), 10 mM EDTA.10 mM Tns and 0.05 M NaOH. Then 0 5 ml of 0.12 M KC1 was added gently and the tubes were kept in a 65°C water bath for 10 min. The tubes were subsequently cooled in ice for 20 min and centrifuged for 10 mm at 1000 g. The supernatant was decanted into a scintillation vial and 1 ml of 0.05 M HC1 was added. The pellet was dissolved in 2X1 ml distilled water at 65°C, vortexed and poured into a scintillation vial. Radioactivities in the supernatant and the pellet fractions were measured in a liquid scintillation counter. 10 6 ) were treated with indicated amounts of cleistanthin B for 24 h The cells were washed twice in PBS and centrifuged at 700 g. The cell pellet was then treated with 100 (il of lysis buffer (1% NP-40, 50mM Tns, 20mM EDTA) After centrifugation for 5 min at 1600 g, the supernatant was collected and the pellet was treated again with the same amount of lysis buffer. The supematants were brought to 1 % SDS and incubated for 2 h with 5 Hg/ml of RNase A at 56°C followed by digestion with proteinase K (2.5 |ig/ml) for at least 2h at 37°C. After addition of 1/2 vol 10 M ammonium acetate the DNA was precipitated with 2.5 vol ethanol, dissolved in gel loading buffer and separated by electrophoresis in 1.5% agarose gels. (Herrmann et al, 1994) Statistical analysis Student's /-test (Student-Newman Keul's test) was used to compare the aberrations between the control and treated cells
Assessment of apoptosis CHO cells (2X
Results
Cytotoxic effects of cleistanthin B
Cleistanthin B was tested for cytotoxicity against a broad spectrum of normal and tumour cell lines. Cytotoxic effect was monitored by determining the viability of cells based on their ability to reduce MTT. The GI50 values for five normal and 10 cancer cell lines were determined and the results are shown in Table I 
Effect of cleistanthin B on the induction of chromatid aberrations
Exposure of CHO cells for 30 min to cleistanthin B resulted in characteristic induction of chromatid-type aberrations (Table  11 and Figure 1 ). Statistical analysis showed that there is a significant difference in the extent of aberrations between the control and the treated cells, at all the concentrations (P < 0.001). In the toxin treated cells a dose-dependent increase in the yield of chromatid aberrations and isochromatid breaks was observed. The exchange aberrations were not dosedependent. At 6 H-g/ml, and above the toxin induced extensive gaps in chromatids (Figure 1 ). The chromatid aberrations occur at doses that are well below those showing significant loss of viability or double-strand breaks in DNA (Table II) .
Effects of cleistanthin B on DNA strand breakage and cell survival CHO cells when treated with low doses of cleistanthin B for a short time (30 min) caused CA, but neither significantly affected the cell viability nor DNA strand breaks (Table II) . Therefore high doses of the toxin were used for viability and strand-break assays tion assay was done under identical conditions as that used for the cell viability assay. Treatment of CHO cells with cleistanthin B at concentrations of 20, 40, 60 and 80 \ig/m\ for 24 h showed 78%, 70, 65 and 62% precipitation of DNA respectively in comparison with the control (Figure 2 ). The dose-dependent decrease in the percentage of precipitated DNA indicate DNA strand breaks.
Induction of apoptosis by cleistanthin B
The induction of strand breaks in DNA and loss of cell viability caused by cleistanthin B may be explained by its ability to induce apoptosis. Cleistanthin B indeed induced programmed cell death in cells that were treated with 10-20 Hg/ml of toxin for 24 h. Agarose gel electrophoresis of DNA from the treated cells showed nucleosome-like ladder pattern (Figure 3) . The DNA fragments in the ladder ranged from 185 bp and its multiples up to 2500 bp.
Induction of micronuclei formation by cleistanthin
The frequency of occurrence of MN in cultured human blood lymphocytes following cleistanthin B treatment is shown in Table III and Figure 4 . Human blood lymphocytes treated with 2-10 Hg/ml of cleistanthin B for 24 and 48 h showed formation of micronuclei. At 24 h of treatment there was a definite increase in MN formation when the cells were exposed to 2-10 |ig/ml of cleistanthin B (Table HI) . The dose-dependant C.P.P.Kumar tt aL 
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increase was more pronounced at 48 h of treatment in which 4-6 (lg/ml of toxin led to an increase of 54% in MN formation over that observed with 2 Discussion Many anti-tumour compounds are derived from plants. Crude extracts of C.collinus plant were reported to possess antitumour effects in epidermal carcinoma cells in culture (Bhakuni et ai, 1969) . In this study, we have purified one of the toxic principles namely cleistanthin B from C.collinus and assessed its anti-proliferative activity using cultured cell lines. Cleistanthin B was found to be toxic to normal and tumour cell lines. Even in the tumour cell lines, some were less sensitive to cleistanthin B than others. The tumour cell line that showed the least sensitivity is the T cell leukaemia (Molt-4) while the cervical carcinoma (SiHa) cells are highly sensitive to this compound. Other tumour cells (Table I) show sensitivity in between the above. Cleistanthin B appears to have low cytotoxicity against normal human cells like bone marrow fibroblasts, peripheral blood lymphocytes and oral fibroblasts (Table I )-CHO cells were as sensitive as human T-cell leukaemia, cervical carcinoma and breast cancer cells. However, it may not be appropriate to compare a hamster cell line with human cell lines. Although human cancer cell lines showed higher sensitivity to this toxin than the three human normal cell types examined (Table I) , the best way of comparison would be with the corresponding normal cells such as comparison of carcinomas with normal epithelial cells.
Treatment of cultured cells with cleistanthin B resulted in the production of many chromatid aberrations. However, there was a significant difference in the survival doses and the dose which induced aberrations. The aberrations were induced at low concentrations of the chemical, well below that which induced significant cell death. At low doses the damage induced by this compound may be repairable and therefore the survival of the cells were not affected. This is also supported by the low induction of MN in cells treated with low concentrations of the toxin for longer time.
The adverse effects of cleistanthin B on DNA and chromosomes and subsequent loss of viability suggest that the cell death caused by the toxin is probably by apoptosis. A number of anti-tumour agents including enediyene, cisplatin, bleomycin, camptothecin doxorubicin and etoposide have been shown to induce cell death by apoptosis (Wrasidlo et al., 1994; Waldman et al., 1996) . The nucleosome-like DNA ladders observed upon electrophoresis of DNA from the toxin-treated cells suggest that cleistanthin also induces cell death by apoptosis. The higher sensitivity of tumour cells to cleistanthin and the apoptotic death caused by this toxin indicate that cleistanthin is a potential candidate for cancer chemotherapy, provided its selectivity against tumour cells versus normal cells can be maintained and enhanced in animal models and humans.
